Trial · NCT03279250
Adverse events98
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 98
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ALT increase | Investigations | Arm A (LHRHa, Apalutamide) | 3 | 34 | 5 |
| other | ALT increase | Investigations | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 8 | 34 | 14 |
| other | Alopecia | Skin and subcutaneous tissue disorders | Arm A (LHRHa, Apalutamide) | 3 | 34 | 3 |
| other | Alopecia | Skin and subcutaneous tissue disorders | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 0 | 34 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Arm A (LHRHa, Apalutamide) | 21 | 34 | 28 |
| other | Anemia | Blood and lymphatic system disorders | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 15 | 34 | 19 |
| other | Anorexia | Metabolism and nutrition disorders | Arm A (LHRHa, Apalutamide) | 2 | 34 | 2 |
| other | Anorexia | Metabolism and nutrition disorders | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 1 | 34 | 1 |
| other | Anxiety | Psychiatric disorders | Arm A (LHRHa, Apalutamide) | 4 | 34 | 4 |
| other | Anxiety | Psychiatric disorders | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 1 | 34 | 1 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Arm A (LHRHa, Apalutamide) | 8 | 34 | 8 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 3 | 34 | 3 |
| other | AST increase | Investigations | Arm A (LHRHa, Apalutamide) | 4 | 34 | 5 |
| other | AST increase | Investigations | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 9 | 34 | 14 |
| other | Bruising | Injury, poisoning and procedural complications | Arm A (LHRHa, Apalutamide) | 2 | 34 | 2 |
| other | Bruising | Injury, poisoning and procedural complications | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 1 | 34 | 1 |
| other | Cholesterol high | Investigations | Arm A (LHRHa, Apalutamide) | 11 | 34 | 12 |
| other | Cholesterol high | Investigations | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 6 | 34 | 7 |
| other | Cognitive disturbance | Nervous system disorders | Arm A (LHRHa, Apalutamide) | 2 | 34 | 2 |
| other | Cognitive disturbance | Nervous system disorders | Arm B (LHRHa, Apalutamide, Abiraterone Acetate) | 0 | 34 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03279250/events